Immucell Corp /DE/ SEC filings ICCC

Immucell Corp /DE/ has 795 filings in SEC EDGAR's recent list, going back to Aug 3, 1995. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report May 13, 2026 Dec 31, 2025
10-K Annual report Mar 30, 2026 Dec 31, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K Annual report Mar 27, 2020 Dec 31, 2019
10-K Annual report Mar 22, 2019 Dec 31, 2018
10-K Annual report Mar 29, 2018 Dec 31, 2017
10-K Annual report Mar 30, 2017 Dec 31, 2016
10-K Annual report Mar 25, 2016 Dec 31, 2015
10-K Annual report Mar 26, 2015 Dec 31, 2014
10-K Annual report Mar 26, 2014 Dec 31, 2013
10-K Annual report Mar 28, 2013 Dec 31, 2012
10-K/A Amended annual report Jan 8, 2013 Dec 31, 2011
10-K Annual report Mar 27, 2012 Dec 31, 2011
10-K Annual report Mar 28, 2011 Dec 31, 2010
ARS Annual report to shareholders Apr 29, 2010 Dec 31, 2009
10-K Annual report Mar 29, 2010 Dec 31, 2009
ARS Annual report to shareholders Apr 30, 2009 Dec 31, 2008
10-K Annual report Mar 27, 2009 Dec 31, 2008
ARS Annual report to shareholders Apr 28, 2008 Dec 31, 2007
10-K Annual report Mar 23, 2006 Dec 31, 2005
10-K Annual report Mar 29, 2005 Dec 31, 2004
10-K Annual report Mar 29, 2004 Dec 31, 2003
ARS Annual report to shareholders May 12, 2003 Dec 31, 2002
10-K Annual report Mar 31, 2003 Dec 31, 2002
ARS Annual report to shareholders May 14, 2002 Dec 31, 2001
10-K Annual report Mar 30, 2001 Dec 31, 2000
10-K Annual report Mar 30, 2000 Dec 31, 1999
10-K Annual report Mar 31, 1999 Dec 31, 1998
10-K Annual report Mar 27, 1998 Dec 31, 1997
10-K Annual report Mar 28, 1997 Dec 31, 1996
10-K Annual report Apr 1, 1996 Dec 31, 1995

Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
ICCC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Portland, ME
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
811641

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.